PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites
Condition: Malignant Ascites Interventions: Drug: Serplulimab; Drug: Molgramostim; Radiation: Hypofractionated radiotherapy/Sterotactic body radiotherapy Sponsor: Second Affiliated Hospital of Soochow University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials